bisoprolol has been researched along with Cardiovascular Stroke in 58 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction." | 10.18 | [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction]. ( Bogár, L; Czopf, L; Debreceni, G; Habon, T; Kónyi, A; Mühl, D; Sárosi, I; Schmidt, E; Tekeres, M; Tóth, K; Zámbó, K, 1997) |
| "Bisoprolol is commonly used to treat moderate or severe chronic stable heart failure, coronary heart disease, and hypertension." | 9.51 | The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency. ( Wang, Y, 2022) |
| "In patients with depressed < or =35% ejection fraction after acute myocardial infarction treatment with low doses of metoprolol, bisoprolol and cardvediolol did not reduce mortality rate in 24-month observation." | 9.12 | [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction]. ( Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J, 2006) |
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 9.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 9.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| " The purpose of this study was to compare the effects of bisoprolol therapy with those of imidapril therapy on left ventricular remodeling after acute myocardial infarction (AMI)." | 9.09 | Long-term effects of bisoprolol compared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency. ( Kojima, S; Kuramochi, M; Matsumoto, Y; Sugi, T; Yano, M; Yoshitomi, Y, 2000) |
| "This study assessed the real-life effectiveness of a single-pill combination (SPC) of bisoprolol/perindopril for controlling blood pressure (BP) and symptoms of angina in patients with hypertension and a history of myocardial infarction (MI)." | 8.31 | Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study. ( Burtsev, Y; Kobalava, Z; Kvasnikov, B, 2023) |
| "To analyze the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI)." | 8.02 | Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI). ( Chen, C; Li, Y; Peng, Y; Wu, X, 2021) |
| "The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats." | 7.96 | Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats. ( Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A, 2020) |
| "Bisoprolol was associated with a significant reduction of 30-day cardiac death and nonfatal MI, while fluvastatin showed a trend for improved outcome." | 7.84 | Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). ( Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F, 2009) |
| "The aims of this study were to explore the changes in expression of myocardial adiponectin (APN), changes in serum APN, and the significance of bisoprolol intervention in acute myocardial infarction (AMI) rats." | 7.77 | Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention. ( Ge, J; Goldstein, S; He, B; Ruiz, G; Wang, Z; Zhang, S, 2011) |
| "We tested the hypothesis that long-term beta-blocker treatment with bisoprolol prevents creatine kinase (CK) and lactate dehydrogenase system changes that occur after chronic myocardial infarction." | 7.69 | Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. ( Ertl, G; Gaudron, P; Hu, K; Ingwall, JS; Laser, A; Neubauer, S; Tian, R, 1996) |
| "The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction." | 6.18 | [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction]. ( Bogár, L; Czopf, L; Debreceni, G; Habon, T; Kónyi, A; Mühl, D; Sárosi, I; Schmidt, E; Tekeres, M; Tóth, K; Zámbó, K, 1997) |
| "Bisoprolol is commonly used to treat moderate or severe chronic stable heart failure, coronary heart disease, and hypertension." | 5.51 | The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency. ( Wang, Y, 2022) |
| "Bisoprolol is a highly beta1-selective beta-blocker, without intrinsic sympathomimetic activity (ISA), and with a plasma elimination half-life of 10-12 h, permitting treatment with one daily dose." | 5.28 | Bisoprolol pilot studies in myocardial infarction. ( de Muinck, ED; Lie, KI; Reck, R; Verkenne, P; von Mengden, HJ, 1990) |
| "In patients with depressed < or =35% ejection fraction after acute myocardial infarction treatment with low doses of metoprolol, bisoprolol and cardvediolol did not reduce mortality rate in 24-month observation." | 5.12 | [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction]. ( Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J, 2006) |
| "The authors performed a double-blinded, placebo-controlled, multicenter trial to compare the effect of bisoprolol with that of placebo on 1-yr composite outcome including cardiovascular mortality, nonfatal myocardial infarction, unstable angina, congestive heart failure, and cerebrovascular insult." | 5.12 | Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-contro ( Bestmann, L; Blumenthal, S; Boltres, A; Borgeat, A; Furrer, L; Hersberger, M; Hofer, C; Kälin, G; Lucchinetti, E; Müller, A; Schulz, C; Spahn, DR; Wacker, J; Zaugg, M; Zollinger, A, 2007) |
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 5.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| " The purpose of this study was to compare the effects of bisoprolol therapy with those of imidapril therapy on left ventricular remodeling after acute myocardial infarction (AMI)." | 5.09 | Long-term effects of bisoprolol compared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency. ( Kojima, S; Kuramochi, M; Matsumoto, Y; Sugi, T; Yano, M; Yoshitomi, Y, 2000) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 5.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| "Because carvedilol is a unique vasodilating β blocker (BB) exerting antioxidant activity and pleiotropic effects, it was theorized that it may confer more potent beneficial effects on cardiovascular mortality and morbidity in acute myocardial infarction (AMI) and heart failure (HF) settings." | 4.89 | Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). ( DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH, 2013) |
| "This study assessed the real-life effectiveness of a single-pill combination (SPC) of bisoprolol/perindopril for controlling blood pressure (BP) and symptoms of angina in patients with hypertension and a history of myocardial infarction (MI)." | 4.31 | Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study. ( Burtsev, Y; Kobalava, Z; Kvasnikov, B, 2023) |
| "The transdermal formulation of bisoprolol may be useful for the early introduction of β-blockers in patients admitted with cardiac symptoms associated with myocardial ischemia or heart failure." | 4.02 | An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms. ( Horiuchi, N; Kobayashi, T; Kobayashi, Y; Nakamura, S; Nakanishi, H; Naruhashi, K; Nozaki, A; Okugawa, H, 2021) |
| "To analyze the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI)." | 4.02 | Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI). ( Chen, C; Li, Y; Peng, Y; Wu, X, 2021) |
| "The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats." | 3.96 | Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats. ( Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A, 2020) |
| "Bisoprolol was associated with a significant reduction of 30-day cardiac death and nonfatal MI, while fluvastatin showed a trend for improved outcome." | 3.84 | Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). ( Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F, 2009) |
| "The aims of this study were to explore the changes in expression of myocardial adiponectin (APN), changes in serum APN, and the significance of bisoprolol intervention in acute myocardial infarction (AMI) rats." | 3.77 | Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention. ( Ge, J; Goldstein, S; He, B; Ruiz, G; Wang, Z; Zhang, S, 2011) |
| "Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4." | 3.72 | [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004) |
| "Bisoprolol (60 mg/kg body weight per day) was given 30 min or 14 days after MI or sham operation." | 3.70 | Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. ( Ertl, G; Gaudron, P; Hu, K, 1998) |
| "To evaluate the antiarrhythmic efficacy of l-sotalol and bisoprolol on inducible ventricular arrhythmias, conscious dogs with 4- to 8-day-old myocardial infarction were studied by programmed electrical stimulation." | 3.69 | Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol. ( Aidonidis, I; Brachmann, J; Hilbel, T; Kuebler, W; Rizos, I, 1994) |
| "We tested the hypothesis that long-term beta-blocker treatment with bisoprolol prevents creatine kinase (CK) and lactate dehydrogenase system changes that occur after chronic myocardial infarction." | 3.69 | Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. ( Ertl, G; Gaudron, P; Hu, K; Ingwall, JS; Laser, A; Neubauer, S; Tian, R, 1996) |
| "The occurrence of sudden cardiac death (SCD) in patients with silent ischemia after myocardial infarction (MI) and the factors facilitating SCD are unknown." | 2.74 | Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). ( Abbate, A; Erne, P; Jamshidi, P; Kobza, R; Pfisterer, M; Schoenenberger, AW; Stuck, AE; Zuber, M, 2009) |
| "Bisoprolol was well tolerated without between group difference in premature treatment withdrawals (82 on placebo, 75 on bisoprolol; NS)." | 2.67 | A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. ( , 1994) |
| "Type 2 diabetes is becoming very common and is closely linked to physical inactivity and obesity." | 2.41 | Beta-blockers and diabetes: the bad guys come good. ( Cruickshank, JM, 2002) |
| "Acute myocardial infarction is rare in pregnancy; however, the emerging trend towards advanced maternal age and the rising prevalence of obesity and diabetes suggest that more cases of myocardial infarction are likely to be encountered in pregnancy." | 1.39 | Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy'). ( Dutton, P; Okunoye, GO, 2013) |
| "Treatment with bisoprolol or captopril largely prevented all of these changes in infarcted hearts." | 1.30 | Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. ( de Groot, M; Dienesch, C; Ertl, G; Horn, M; Hu, K; Hügel, S; Neubauer, S; Remkes, H, 1999) |
| "Bisoprolol is a highly beta1-selective beta-blocker, without intrinsic sympathomimetic activity (ISA), and with a plasma elimination half-life of 10-12 h, permitting treatment with one daily dose." | 1.28 | Bisoprolol pilot studies in myocardial infarction. ( de Muinck, ED; Lie, KI; Reck, R; Verkenne, P; von Mengden, HJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.72) | 18.7374 |
| 1990's | 13 (22.41) | 18.2507 |
| 2000's | 26 (44.83) | 29.6817 |
| 2010's | 12 (20.69) | 24.3611 |
| 2020's | 6 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, K | 1 |
| Desai, H | 1 |
| Sharm, N | 1 |
| Laddha, M | 1 |
| Hansora, K | 1 |
| Vazirani, P | 1 |
| Wang, Y | 1 |
| Kobalava, Z | 1 |
| Kvasnikov, B | 1 |
| Burtsev, Y | 1 |
| Krasnova, M | 1 |
| Kulikov, A | 1 |
| Okovityi, S | 1 |
| Ivkin, D | 1 |
| Karpov, A | 1 |
| Kaschina, E | 1 |
| Smirnov, A | 1 |
| Nozaki, A | 1 |
| Kobayashi, T | 1 |
| Naruhashi, K | 1 |
| Okugawa, H | 1 |
| Horiuchi, N | 1 |
| Nakanishi, H | 1 |
| Kobayashi, Y | 1 |
| Nakamura, S | 1 |
| Chen, C | 1 |
| Wu, X | 1 |
| Li, Y | 1 |
| Peng, Y | 1 |
| Zhong, Y | 1 |
| Rao, L | 1 |
| Okunoye, GO | 1 |
| Dutton, P | 1 |
| Surkova, EA | 1 |
| Dupliakov, DV | 1 |
| Furuichi, Y | 1 |
| Sakamoto, A | 1 |
| Kmietowicz, Z | 1 |
| Seo, GW | 1 |
| Kim, DK | 1 |
| Kim, KH | 1 |
| Seol, SH | 1 |
| Jin, HY | 1 |
| Yang, TH | 1 |
| Ahn, Y | 1 |
| Jeong, MH | 1 |
| Song, PS | 1 |
| Kim, DI | 1 |
| Andersen, SS | 1 |
| Hansen, ML | 1 |
| Gislason, GH | 1 |
| Folke, F | 1 |
| Schramm, TK | 1 |
| Fosbøl, E | 1 |
| Sørensen, R | 1 |
| Rasmussen, S | 1 |
| Abildstrøm, SZ | 1 |
| Madsen, M | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Dunkelgrun, M | 1 |
| Boersma, E | 4 |
| Schouten, O | 2 |
| Koopman-van Gemert, AW | 1 |
| van Poorten, F | 1 |
| Bax, JJ | 4 |
| Thomson, IR | 3 |
| Poldermans, D | 4 |
| Kondratyeva, DS | 1 |
| Afanasyev, SA | 1 |
| Ligacheva, NA | 1 |
| Popov, SV | 1 |
| Krivolapov, SN | 1 |
| Schoenenberger, AW | 2 |
| Kobza, R | 1 |
| Jamshidi, P | 1 |
| Zuber, M | 2 |
| Abbate, A | 1 |
| Stuck, AE | 1 |
| Pfisterer, M | 2 |
| Erne, P | 2 |
| Duncker, DJ | 1 |
| Boontje, NM | 1 |
| Merkus, D | 1 |
| Versteilen, A | 1 |
| Krysiak, J | 1 |
| Mearini, G | 1 |
| El-Armouche, A | 1 |
| de Beer, VJ | 1 |
| Lamers, JM | 1 |
| Carrier, L | 1 |
| Walker, LA | 1 |
| Linke, WA | 1 |
| Stienen, GJ | 1 |
| van der Velden, J | 1 |
| González Oliva, JC | 1 |
| Saurina i Solé, A | 1 |
| Pou Potau, M | 1 |
| Salas Gama, KR | 1 |
| Ramírez de Arellano Serna, M | 1 |
| Remme, WJ | 1 |
| Zhang, S | 1 |
| He, B | 1 |
| Goldstein, S | 1 |
| Ge, J | 1 |
| Wang, Z | 1 |
| Ruiz, G | 1 |
| Konishi, M | 1 |
| Haraguchi, G | 1 |
| Yoshikawa, S | 1 |
| Kimura, S | 1 |
| Inagaki, H | 1 |
| Isobe, M | 1 |
| Seino, Y | 1 |
| DiNicolantonio, JJ | 1 |
| Lavie, CJ | 1 |
| Fares, H | 1 |
| Menezes, AR | 1 |
| O'Keefe, JH | 1 |
| Cruickshank, JM | 1 |
| Kanopskiĭ, SG | 1 |
| Staritskiĭ, AG | 1 |
| Bozhko, AA | 1 |
| Visser, L | 1 |
| Kertai, MD | 1 |
| Klein, J | 1 |
| van Urk, H | 3 |
| Simoons, ML | 1 |
| van de Ven, LL | 3 |
| Vermeulen, M | 1 |
| Lameris, TW | 1 |
| Ivanova, LA | 1 |
| Kanorskii, SG | 1 |
| Rostovtseva, ON | 1 |
| Halil Sufian, B | 1 |
| Galenko-Yaroshevskii, PA | 1 |
| Kowey, PR | 1 |
| Hohnloser, SH | 1 |
| Dorian, P | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Israel, CW | 1 |
| Fain, E | 1 |
| Champagne, J | 1 |
| Connolly, SJ | 1 |
| Tarasov, NI | 1 |
| Kokov, AN | 1 |
| Barbarash, LS | 1 |
| Ruta, J | 1 |
| Ptaszyński, P | 1 |
| Maciejewski, M | 1 |
| Goch, JH | 1 |
| Chizyński, K | 1 |
| Zaugg, M | 1 |
| Bestmann, L | 1 |
| Wacker, J | 1 |
| Lucchinetti, E | 1 |
| Boltres, A | 1 |
| Schulz, C | 1 |
| Hersberger, M | 1 |
| Kälin, G | 1 |
| Furrer, L | 1 |
| Hofer, C | 1 |
| Blumenthal, S | 1 |
| Müller, A | 1 |
| Zollinger, A | 1 |
| Spahn, DR | 1 |
| Borgeat, A | 1 |
| Burckhardt, D | 1 |
| Kiowski, W | 1 |
| Dubach, P | 1 |
| Resink, T | 1 |
| Smedema, JP | 1 |
| Berlion, AE | 1 |
| Morkel, H | 1 |
| Aidonidis, I | 1 |
| Rizos, I | 1 |
| Hilbel, T | 1 |
| Kuebler, W | 1 |
| Brachmann, J | 1 |
| Laser, A | 1 |
| Neubauer, S | 2 |
| Tian, R | 1 |
| Hu, K | 3 |
| Gaudron, P | 2 |
| Ingwall, JS | 1 |
| Ertl, G | 3 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| Sárosi, I | 1 |
| Debreceni, G | 1 |
| Mühl, D | 1 |
| Kónyi, A | 1 |
| Bogár, L | 1 |
| Tekeres, M | 1 |
| Tóth, K | 1 |
| Habon, T | 1 |
| Czopf, L | 1 |
| Zámbó, K | 1 |
| Schmidt, E | 1 |
| Kendall, MJ | 1 |
| Blankensteijn, JD | 1 |
| Baars, HF | 2 |
| Yo, TI | 1 |
| Trocino, G | 2 |
| Vigna, C | 2 |
| Roelandt, JR | 2 |
| Lee, TH | 1 |
| Hügel, S | 1 |
| Horn, M | 1 |
| de Groot, M | 1 |
| Remkes, H | 1 |
| Dienesch, C | 1 |
| Dickerson, LM | 1 |
| Carek, PJ | 1 |
| Feldman, T | 1 |
| Fusman, B | 1 |
| McKinsey, JF | 1 |
| Yoshitomi, Y | 1 |
| Kojima, S | 1 |
| Yano, M | 1 |
| Sugi, T | 1 |
| Matsumoto, Y | 1 |
| Kuramochi, M | 1 |
| Mollhoff, T | 1 |
| Schmidt, C | 1 |
| Van Aken, H | 1 |
| Berendes, E | 1 |
| Rolf, N | 1 |
| Buerkle, H | 1 |
| Prichard, BN | 1 |
| Robin, JM | 1 |
| Paelinck, B | 1 |
| Scheffer, MG | 1 |
| Verrostte, JM | 1 |
| van Hemel, NM | 1 |
| Kingma, JH | 1 |
| de Muinck, ED | 1 |
| Lie, KI | 1 |
| von Mengden, HJ | 1 |
| Reck, R | 1 |
| Verkenne, P | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Gülker, H | 1 |
| Houle, MS | 1 |
| Altschuld, RA | 1 |
| Billman, GE | 1 |
| Leizorovicz, A | 1 |
| Lechat, P | 1 |
| Cucherat, M | 1 |
| Bugnard, F | 1 |
| Ogawa, T | 1 |
| Hieda, N | 1 |
| Sugiyama, S | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Ozawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Randomized Controlled Trial of Loading Dose Statins for the Prevention of Cardiovascular Complications in High-Risk Non-Cardiac Surgery[NCT01543555] | Phase 3 | 648 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [NCT00257959] | Phase 4 | 400 participants | Interventional | 2001-01-31 | Completed | ||
| Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure[NCT00832442] | 18,240 participants (Anticipated) | Observational | 2008-08-31 | Enrolling by invitation | |||
| Using Heart Rate Variability to Analyze the Effect of Beta Blockers on Intermediate Risk Patients Undergoing Laparoscopic Surgical Procedures[NCT01330654] | 0 participants (Actual) | Interventional | 2011-03-31 | Withdrawn (stopped due to no patients were enrolled. Study was closed prior to study start.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for bisoprolol and Cardiovascular Stroke
| Article | Year |
|---|---|
[Effect of therapy with bisoprolol in postoperative period on rate of cardiac complications of extracardiac surgical interventions].
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Humans; Meta-Analysis as Topic; Myocardial Infar | 2013 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvast | 2014 |
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acid | 2009 |
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; E | 2013 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabet | 2002 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Ca | 2005 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Calcium Channel Blockers; Female; Humans; Male; Middle Aged | 1997 |
Antiarrhythmic properties of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Bisoprolol; Humans; Metoprolol; Myocar | 1990 |
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Female; Heart Failure; Hospitalization; Humans; Male; Middl | 2002 |
16 trials available for bisoprolol and Cardiovascular Stroke
| Article | Year |
|---|---|
The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency.
Topics: Bisoprolol; Heart Failure; Humans; Meta-Analysis as Topic; Myocardial Infarction; Stroke Volume; Ven | 2022 |
Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Carbazo | 2015 |
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acid | 2009 |
Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angioplasty, Balloon, Coronary; Antihypertensi | 2009 |
Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Ang | 2011 |
Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors | 2004 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
[MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Drug | 2006 |
[Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon, Coronary; Bisoprolol; | 2006 |
Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-contro
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Bisoprolol; Cardiomyopathy, Dilated; Cardiovascular | 2007 |
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Bisoprolol; Death, Su | 2007 |
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Cardiomyopathy, Dilated; Dose-Response | 1994 |
[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Calcium Channel Blockers; Female; Humans; Male; Middle Aged | 1997 |
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Female; Heart Diseases; Heart Rate; Humans; Incidence | 1999 |
Long-term effects of bisoprolol compared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 2000 |
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
Topics: Adrenergic beta-Antagonists; Aorta, Abdominal; Bisoprolol; Dobutamine; Echocardiography; Femoral Art | 2001 |
34 other studies available for bisoprolol and Cardiovascular Stroke
| Article | Year |
|---|---|
To Evaluate the 'Real World' Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.
Topics: Bisoprolol; Female; Glycated Hemoglobin; Heart Failure; Humans; Lipids; Male; Middle Aged; Myocardia | 2022 |
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Femal | 2023 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, A | 2020 |
An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
Topics: Acute Coronary Syndrome; Acute Disease; Administration, Cutaneous; Adrenergic beta-1 Receptor Antago | 2021 |
Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
Topics: Aminobutyrates; Biphenyl Compounds; Bisoprolol; Cardiac Rehabilitation; Drug Combinations; Heart Fai | 2021 |
Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Atrioventricular Block; Bisoprolol; Drug Administration Schedule | 2017 |
Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy').
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Adult; Aspirin; Bisoprolol; Ch | 2013 |
Researchers "disappointed" that influential study was not retracted.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Humans; Myocardial Infarction; Postoperative Com | 2014 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male | 2009 |
Changes in the rhythmoinotropic dependence of the myocardium in rats with postinfarction cardiosclerosis after beta1-adrenoreceptor blocking.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Calcium; Heart Ventricles; Male; Myocardial Infarc | 2009 |
Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Topics: Actin Cytoskeleton; Adrenergic beta-Antagonists; Animals; Bisoprolol; Calcium Signaling; Cardiac Myo | 2009 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium | 2010 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Tria | 2010 |
Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention.
Topics: Adiponectin; Animals; Bisoprolol; Female; Gene Expression; Immunohistochemistry; Myocardial Infarcti | 2011 |
Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagon | 2011 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Diseases; Drug Therapy, Combination; | 2004 |
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Asp | 2009 |
Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
Topics: Animals; Bisoprolol; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Female | 1994 |
Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Citrate (si)-Synthase; Creatine; Creatine Kinase; | 1996 |
Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Body Weight; Disease Models, Animal; Dose-Response | 1998 |
Possible mechanisms of action in the positive effect of beta blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Death, Sudden, Cardiac; Heart Failure; Humans; Myocardial I | 1999 |
Reducing cardiac risk in noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Incidence; Myocardial Infarction; M | 1999 |
Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adrenergic beta-Antagonists; Angiotensin-Converting Enz | 1999 |
Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Female; Heart Diseases; Humans; Male; Multicenter Stu | 2000 |
Beta-blockade for patients undergoing vascular surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Humans; Myocardial Infarction; Postoperative Complications; | 2000 |
[Non-cardiac vascular surgery. Perioperative beta blockade protects the heart].
Topics: Adrenergic beta-Antagonists; Aged; Aortic Aneurysm, Abdominal; Bisoprolol; Clinical Trials as Topic; | 2001 |
Perioperative myocardial infarction (PMI): a never-ending story.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Anesthesia, Spinal; Bisoprolol; Humans; Incidence; | 2001 |
Beta-blockade and surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Myocardial Infarction; Myocardial I | 2001 |
Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrioventric | 1990 |
Bisoprolol pilot studies in myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Cardiac | 1990 |
[Vascular interventions. Beta blocker protects the heart].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Bisoprolol; Clinical Trials as Topic; Huma | 2001 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2001 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |